This report describes the case of a patient with erythrodermic psoriasis who had failed all previous therapies and been hospitalized numerous times over a 12-year period that responded dramatically to treatment with infliximab. The potential utility of infliximab as a therapeutic alternative for erythrodermic psoriasis is discussed.
Erythrodermic, recalcitrant psoriasis: Clinical resolution with infliximab / Rongioletti, F; Borenstein, M; Kirsner, R; Kerdel, F. - In: THE JOURNAL OF DERMATOLOGICAL TREATMENT. - ISSN 0954-6634. - 14:4(2003), pp. 222-225. [10.1080/09546630310010895]
Erythrodermic, recalcitrant psoriasis: Clinical resolution with infliximab
RONGIOLETTI F;
2003-01-01
Abstract
This report describes the case of a patient with erythrodermic psoriasis who had failed all previous therapies and been hospitalized numerous times over a 12-year period that responded dramatically to treatment with infliximab. The potential utility of infliximab as a therapeutic alternative for erythrodermic psoriasis is discussed.File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
